Clinical Trial Update: Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) [Phase 4]

View source ↗

Summary

Phase 4 trial update on metformin for ectopic fat deposition and metabolic markers in polycystic ovary syndrome; the study was terminated and results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease
• Polycystic Ovary Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Columbia University | Conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease | Phase 4 | Status: TERMINATED | Results posted: 2025-07-02